Ccl1

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

CC-chemokine ligand 1; Chemokines (C-C Motif) Ligand 1; I-309; Inflammatory Cytokines I-309; P500; SCYA1; SISe; Small Inducible Cytokines A1; TCA3; T Lymphocyte-Secreted Protein I-309

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

CCL1 (CC-chemokine ligand 1) is a cytokine of the CC chemokine family, which is encoded by a gene on chromosome 17 (gene locus 17: 34.36 - 34.36). CCL1 is involved in inflammatory processes. The chemokine also plays a role in apoptosis, angiogenesis and in the pathogenesis of tumours.

CCL1 is produced by a number of immune cells (peripheral mononuclear cells such as monocytes, activated T lymphocytes, endothelial cells). The proinflammatory mediators TNF alpha, NF-kappaB, IL-1beta increase the production of CCL1.

CCL1 binds to the CCR8-receptor which is expressed by melanoma cells and sinusoidal (not in peripheral) lymphatic endothelia of the lymph node. CCL1 acts chemotactically on various immune cells, including monocytes, Th2 cells, Tregs, NK cells, immature B cells and dendritic cells.

General informationThis section has been translated automatically.

In experimental approaches it could be shown that CCL1 as well as the chemokines CCL22, CCL17, MDC (monocyte-derived chemokine), TARC (thymus- and activation-regulated chemokine) influence the migration of lymphocytes especially of Th2-lymphocytes. CCL1 and its receptor play a role in the inflammation of bronchial asthma and lesional skin (not in serum) in patients with atopic dermatitis. Remarkably, CCL1-induced chemotaxis on inflammatory cells can be reversed by a viral recombinant molluscum-contagiosum protein(rMC148p). In primary sclerosing cholangitis (K83.0) there is a significant increase in interleukin-4, interleukin-10 as well as CCL1 and CCR8.

LiteratureThis section has been translated automatically.

  1. Asai A et al (2012)CCL1 released from M2b macrophages is essentially required for the maintenance of their properties. J Leukoc Biol 92:859-867.
  2. The S et al (2013) tumor cell entry into the lymph node is controlled by CCL1 chemokines expressed by lymph node lymphatic sinuses. J Exp Med 210:1509-1528.
  3. Denis C et al (2012) C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity. PLoS One.7:e34199.
  4. Hoelzinger DB et al (w2010) Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol 184:6833-6842.
  5. Kim HO et al (2012) Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin Exp Dermatol 37:521 526.
  6. N'Diaye M et al (2009) TNFalpha- and NF-kappaB-dependent induction of the chemokine CCL1 in human macrophages exposed to the atherogenic lipoprotein(a). Life Sci 84:451-457.
  7. Paslin DA et al (2015) A Molluscum contagiosum fusion protein inhibits CCL1-induced chemotaxis of cells expressing CCR8 and penetrates human neonatal foreskins: clinical applications proposed. Arch Dermatol Res 307:275-280.
  8. Zen Y et al (2013) Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J Hepatol 59:1059-1064.

Authors

Last updated on: 29.10.2020